A weekly briefing on what changed this week in healthcare's primary-source data — and what it means for the people who have to act on it.
What you will receive
- The week in shortages. New FDA drug shortages, status changes, and resolutions, with the operational context that a pharmacist or supply manager needs to read past the headline.
- Discontinuations and recalls. Manufacturer-initiated discontinuations and FDA enforcement actions, organized by therapeutic area.
- Reimbursement and revenue-cycle signals. When a shortage, recall, or discontinuation reshapes utilization or coding, we flag the downstream implications for revenue-cycle and managed-care teams.
- Data notes. Changes to the primary-source feeds themselves — new openFDA endpoints, schema revisions, methodology updates — that anyone working from this data should know about.
Who it is for
Pharmacists and pharmacy directors. Hospital supply chain teams. Revenue-cycle and managed-care professionals. Clinicians who want a faster way to know what is going on with the drugs they prescribe. Researchers and journalists working in healthcare data. Anyone who benefits from primary-source data interpreted by people who read it every day.
What it is not
- Not medical advice. Not clinical guidance.
- Not advertising. We do not accept sponsorship from drug manufacturers, pharmacies, payers, or government agencies.
- Not a re-publisher. We do not forward press releases or repeat manufacturer statements without context.